94 related articles for article (PubMed ID: 1549696)
1. Differentiation of hepatocellular carcinomas from hyperplastic nodules induced in rat liver with ferrite-enhanced MR imaging.
Kawamori Y; Matsui O; Kadoya M; Yoshikawa J; Demachi H; Takashima T
Radiology; 1992 Apr; 183(1):65-72. PubMed ID: 1549696
[TBL] [Abstract][Full Text] [Related]
2. Development of hepatomas in hyperplastic nodules induced in the rat liver: detection with superparamagnetic iron oxide-enhanced magnetic resonance imaging.
Yamamoto H; Yamashita Y; Takahashi M
Acad Radiol; 1996 Apr; 3(4):330-5. PubMed ID: 8796683
[TBL] [Abstract][Full Text] [Related]
3. Adenomatous hyperplastic nodules in the cirrhotic liver: differentiation from hepatocellular carcinoma with MR imaging.
Matsui O; Kadoya M; Kameyama T; Yoshikawa J; Arai K; Gabata T; Takashima T; Nakanuma Y; Terada T; Ida M
Radiology; 1989 Oct; 173(1):123-6. PubMed ID: 2550995
[TBL] [Abstract][Full Text] [Related]
4. [Superparamagnetic iron oxide-enhanced magnetic resonance imaging of hepatocellular carcinoma in rats].
Liu X; Xu YK; Huang QL; Wu YK
Di Yi Jun Yi Da Xue Xue Bao; 2002 Dec; 22(12):1061-5. PubMed ID: 12480574
[TBL] [Abstract][Full Text] [Related]
5. Hepatic micrometastases in the rat: ferrite-enhanced MR imaging.
Tsang YM; Stark DD; Chen MC; Weissleder R; Wittenberg J; Ferrucci JT
Radiology; 1988 Apr; 167(1):21-4. PubMed ID: 3347724
[TBL] [Abstract][Full Text] [Related]
6. Ferrite particles: a new magnetic resonance imaging contrast agent. Lack of acute or chronic hepatotoxicity after intravenous administration.
Bacon BR; Stark DD; Park CH; Saini S; Groman EV; Hahn PF; Compton CC; Ferrucci JT
J Lab Clin Med; 1987 Aug; 110(2):164-71. PubMed ID: 3598345
[TBL] [Abstract][Full Text] [Related]
7. [Hepatic and hepatocarcinoma magnetic resonance: comparison of the results obtained with paramagnetic (gadolinium) and superparamagnetic (iron oxide particles) contrast media].
Castoldi MC; Fauda V; Scaramuzza D; Vergnaghi D
Radiol Med; 2000 Sep; 100(3):160-7. PubMed ID: 11148882
[TBL] [Abstract][Full Text] [Related]
8. Diagnostic value of a superparamagnetic iron oxide in MR imaging of chronic liver disease in an animal model.
Kreft B; Block W; Dombrowski F; Fackeldey A; Bachmann R; Mühlhäuser J; Träber F; Oksendal A; Pfeifer U; Schild HH
AJR Am J Roentgenol; 1998 Mar; 170(3):661-8. PubMed ID: 9490949
[TBL] [Abstract][Full Text] [Related]
9. Liver tumors in cirrhosis: experimental study with SPIO-enhanced MR imaging.
Clement O; Frija G; Chambon C; Schouman-Clayes E; Mosnier JF; Poupon MF; Balkau B
Radiology; 1991 Jul; 180(1):31-6. PubMed ID: 2052718
[TBL] [Abstract][Full Text] [Related]
10. Dual contrast enhanced magnetic resonance imaging of the liver with superparamagnetic iron oxide followed by gadolinium for lesion detection and characterization.
Kubaska S; Sahani DV; Saini S; Hahn PF; Halpern E
Clin Radiol; 2001 May; 56(5):410-5. PubMed ID: 11384141
[TBL] [Abstract][Full Text] [Related]
11. Ferrite-enhanced MR imaging of hepatic lymphoma: an experimental study in rats.
Weissleder R; Stark DD; Compton CC; Wittenberg J; Ferrucci JT
AJR Am J Roentgenol; 1987 Dec; 149(6):1161-5. PubMed ID: 3318339
[TBL] [Abstract][Full Text] [Related]
12. Fast multiplanar spoiled gradient-recalled imaging of the liver: pulse sequence optimization and comparison with spin-echo MR imaging.
Low RN; Francis IR; Herfkens RJ; Jeffrey RB; Glazer GM; Foo TK; Shimakawa A; Pelc NJ
AJR Am J Roentgenol; 1993 Mar; 160(3):501-9. PubMed ID: 8381572
[TBL] [Abstract][Full Text] [Related]
13. [Magnetic resonance tomography of focal liver and spleen lesions. Experiences using ferrite, a new RES-specific MR contrast medium].
Rummeny E; Weissleder R; Stark DD; Elizondo G; Ferrucci JT
Radiologe; 1988 Aug; 28(8):380-6. PubMed ID: 3174975
[TBL] [Abstract][Full Text] [Related]
14. Ferrite particles: a superparamagnetic MR contrast agent for the reticuloendothelial system.
Saini S; Stark DD; Hahn PF; Wittenberg J; Brady TJ; Ferrucci JT
Radiology; 1987 Jan; 162(1 Pt 1):211-6. PubMed ID: 3786765
[TBL] [Abstract][Full Text] [Related]
15. Ferrite particles: a superparamagnetic MR contrast agent for enhanced detection of liver carcinoma.
Saini S; Stark DD; Hahn PF; Bousquet JC; Introcasso J; Wittenberg J; Brady TJ; Ferrucci JT
Radiology; 1987 Jan; 162(1 Pt 1):217-22. PubMed ID: 3786766
[TBL] [Abstract][Full Text] [Related]
16. T2-weighted MR imaging in the assessment of cirrhotic liver.
Hussain HK; Syed I; Nghiem HV; Johnson TD; Carlos RC; Weadock WJ; Francis IR
Radiology; 2004 Mar; 230(3):637-44. PubMed ID: 14739306
[TBL] [Abstract][Full Text] [Related]
17. Pyogenic liver abscess: contrast-enhanced MR imaging in rats.
Weissleder R; Saini S; Stark DD; Elizondo G; Compton C; Wittenberg J; Ferrucci JT
AJR Am J Roentgenol; 1988 Jan; 150(1):115-20. PubMed ID: 3257107
[TBL] [Abstract][Full Text] [Related]
18. Superparamagnetic iron oxide: clinical application as a contrast agent for MR imaging of the liver.
Stark DD; Weissleder R; Elizondo G; Hahn PF; Saini S; Todd LE; Wittenberg J; Ferrucci JT
Radiology; 1988 Aug; 168(2):297-301. PubMed ID: 3393649
[TBL] [Abstract][Full Text] [Related]
19. Detection and characterization of hepatocellular carcinoma in rats with liver cirrhosis: diagnostic value of combined use of MR positive and negative contrast agents.
Guo DM; Qiu TS; Bian J; Liu SF; Wang CZ
Hepatobiliary Pancreat Dis Int; 2009 Feb; 8(1):65-70. PubMed ID: 19208518
[TBL] [Abstract][Full Text] [Related]
20. Ferrite particles for bowel contrast in MR imaging: design issues and feasibility studies.
Hahn PF; Stark DD; Saini S; Lewis JM; Wittenberg J; Ferrucci JT
Radiology; 1987 Jul; 164(1):37-41. PubMed ID: 3588924
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
